JP2011527709A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527709A5
JP2011527709A5 JP2011517670A JP2011517670A JP2011527709A5 JP 2011527709 A5 JP2011527709 A5 JP 2011527709A5 JP 2011517670 A JP2011517670 A JP 2011517670A JP 2011517670 A JP2011517670 A JP 2011517670A JP 2011527709 A5 JP2011527709 A5 JP 2011527709A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
azithromycin
subject
effective amount
blepharitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011517670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527709A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/050311 external-priority patent/WO2010006306A1/en
Publication of JP2011527709A publication Critical patent/JP2011527709A/ja
Publication of JP2011527709A5 publication Critical patent/JP2011527709A5/ja
Withdrawn legal-status Critical Current

Links

JP2011517670A 2008-07-10 2009-07-10 眼瞼炎の治療方法 Withdrawn JP2011527709A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7977208P 2008-07-10 2008-07-10
US61/079,772 2008-07-10
PCT/US2009/050311 WO2010006306A1 (en) 2008-07-10 2009-07-10 Method of treating blepharitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014190105A Division JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Publications (2)

Publication Number Publication Date
JP2011527709A JP2011527709A (ja) 2011-11-04
JP2011527709A5 true JP2011527709A5 (https=) 2012-07-12

Family

ID=41507457

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011517670A Withdrawn JP2011527709A (ja) 2008-07-10 2009-07-10 眼瞼炎の治療方法
JP2014190105A Ceased JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014190105A Ceased JP2014240433A (ja) 2008-07-10 2014-09-18 眼瞼炎の治療方法

Country Status (7)

Country Link
US (1) US8349806B2 (https=)
EP (1) EP2313103B1 (https=)
JP (2) JP2011527709A (https=)
AU (1) AU2009268372B2 (https=)
CA (1) CA2730120A1 (https=)
MX (1) MX2011000247A (https=)
WO (1) WO2010006306A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292683A1 (en) 2000-09-15 2002-03-26 Bruder Healthcare Company Wound and therapy compress and dressing
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
JP2011527709A (ja) 2008-07-10 2011-11-04 インスパイアー ファーマシューティカルズ，インコーポレイティド 眼瞼炎の治療方法
EP2393355A4 (en) * 2009-01-23 2012-07-25 Inspire Pharmaceuticals Inc METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN
WO2012092378A1 (en) * 2010-12-29 2012-07-05 Inspire Pharmaceuticals, Inc. Method for treating blepharitis
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
CA2840626A1 (en) * 2011-06-29 2013-01-03 Insite Vision Incorporated Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
WO2013191167A1 (ja) * 2012-06-19 2013-12-27 参天製薬株式会社 ヘアレス動物の眼瞼状態の変化方法
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
CN104045674B (zh) * 2014-05-21 2017-01-04 丽珠医药集团股份有限公司 一种阿奇霉素的制备方法
CN105106109A (zh) * 2015-09-11 2015-12-02 江苏锦宇环境工程有限公司 一种阿奇霉素缓释滴眼剂的制备方法
KR20180081597A (ko) * 2015-12-22 2018-07-16 니치유 가부시키가이샤 누액 유층 안정화제 및 이것을 함유하는 점안제
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
CN109381707B (zh) * 2017-08-03 2022-02-15 沈阳药科大学 一种阿奇霉素离子对脂质体滴眼液及其制备方法
JP2023133646A (ja) * 2020-06-26 2023-09-27 参天製薬株式会社 脂質分泌促進剤
US20220160668A1 (en) * 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye
US20240050446A1 (en) * 2021-02-25 2024-02-15 Sun Pharmaceutical Industries Limited Dexamethasone for treatment of blepharitis

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6455583B1 (en) * 1998-05-08 2002-09-24 The University Of Miami Method for treating meibomian gland disease
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US7063857B1 (en) * 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US7332470B2 (en) * 2003-04-15 2008-02-19 The Regents Of The University Of California Methods and compositions for treating ocular disease
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US20050137205A1 (en) * 2003-12-22 2005-06-23 Van Breen Eduard T. Formulation for treating periocular disease
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
US8663639B2 (en) * 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
JP2009514969A (ja) * 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
EP1945227A4 (en) * 2005-11-09 2009-09-30 Dow Pharmaceutical Sciences AZITHROMYCIN FOR THE TREATMENT OF GRANULOMATOUS ROSACEA
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
BRPI0714815A2 (pt) * 2006-08-07 2013-05-21 Bausch & Lomb composiÇço, e, uso de um (a) agonista e (b) um agente anti-infeccioso
US11078262B2 (en) * 2007-04-30 2021-08-03 Allergan, Inc. High viscosity macromolecular compositions for treating ocular conditions
US20080286338A1 (en) * 2007-05-15 2008-11-20 Boston Foundation For Sight Drug delivery system with scleral lens
JP2011527709A (ja) 2008-07-10 2011-11-04 インスパイアー ファーマシューティカルズ，インコーポレイティド 眼瞼炎の治療方法
EP2393355A4 (en) 2009-01-23 2012-07-25 Inspire Pharmaceuticals Inc METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN

Similar Documents

Publication Publication Date Title
JP2011527709A5 (https=)
WO2021126320A9 (en) Treatment of amyotrophic lateral sclerosis and related disorders
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX2022014313A (es) Formulaciones para administracion oral de agentes activos con perfil de absorcion controlada.
JP2014507482A5 (https=)
BR112013020533A2 (pt) silicato de zircônio microporoso para o tratamento de hipercalemia
HRP20180237T4 (hr) Metode za liječenje hcv-a
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
PH12014500472A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
JP2015025011A5 (https=)
NZ602510A (en) Treatment of lupus nephritis using laquinimod
JP2015523546A5 (https=)
EA201490163A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
JP2013231087A5 (https=)
EA201491606A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
MX382065B (es) Inhibidores de la quinurenina-3-monooxigenasa, sus composiciones farmacéuticas, y métodos para su uso.
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
JP2017002035A5 (https=)
HRP20190561T1 (hr) Postupci liječenja bolesti oka povezanih s upalom i vaskularnom proliferacijom
EP2796450A4 (en) 6-AMINOPYRIDIN-3-OL DERIVATIVES OR PHARMACEUTICAL SALTS AND / OR PHARMACEUTICAL COMPOSITION THEREOF AS ACTIVE AGENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES
EA201490166A1 (ru) Фторированные арилалкиламинокарбоксамидные производные
MX2010010455A (es) Formas solidas de un compuesto fosfoindol anti-vih.